Medicare Enrolled

Dr. Michelle Simmons, FNP-C

Nurse Practitioner - Primary Care · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3600 GASTON AVE STE 360, Dallas, TX 75246
2148203971
In practice since 2015 (10 years)
NPI: 1306215660 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Simmons from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Simmons? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Simmons

Dr. Michelle Simmons is a nurse practitioner - primary care in Dallas, TX, with 10 years in practice. Based on federal Medicare data, Dr. Simmons performed 1,029 Medicare services across 536 unique beneficiaries.

Between the years covered by Open Payments, Dr. Simmons received a total of $6,533 from 42 pharmaceutical and/or device companies across 346 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - primary care. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Simmons is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ Top 16% volume in TX$ $6,533 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,029
Medicare services
Top 16% in TX for nurse practitioner - primary care
536
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~103 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms229$110$1,839
Drug screening test228$60$500
Office visit, established patient (30-39 min)174$72$375
Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month119$33$300
Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days114$34$271
Office visit, established patient (20-29 min)98$56$275
Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, each additional 20 minutes per calendar month35$27$296
Set-up and patient education for remote monitoring of therapy32$13$293
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,533
Total received (2021-2024)
Avg $1,633/year across 4 years
Top 3% in TX for nurse practitioner - primary care
42
Companies
346
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,480 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$54 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,815
2023
$1,816
2022
$1,615
2021
$1,287

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Collegium Pharmaceutical, Inc.
$1,310
ABBVIE INC.
$846
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$760
Forte Bio-Pharma LLC
$474
BioDelivery Sciences International, Inc.
$214
GENZYME CORPORATION
$200
Scilex Pharmaceuticals Inc.
$197
Merck Sharp & Dohme LLC
$190
Lilly USA, LLC
$184
Abbott Laboratories
$180
FORTE BIO-PHARMA LLC
$168
SCILEX PHARMACEUTICALS INC.
$132
SK Life Science, Inc.
$124
Medtronic, Inc.
$111
Averitas Pharma Inc.
$109
Amgen Inc.
$104
PFIZER INC.
$104
Kyowa Kirin, Inc.
$96
RedHill Biopharma Inc.
$80
Valinor Pharma, LLC
$74
IBSA Pharma Inc.
$73
Vertos Medical, Inc.
$71
GRT US Holding, Inc.
$70
Biohaven Pharmaceutical Holding Company Ltd.
$67
SPR Therapeutics, Inc
$58
Hikma Pharmaceuticals USA
$55
Brainsway USA INC
$54
Almatica Pharma LLC
$49
USWM, LLC
$44
Pacira Therapeutics, Inc.
$42
Lundbeck LLC
$41
Allergan, Inc.
$35
Nevro Corp.
$33
Baudax Bio Inc.
$29
Saluda Medical Americas, Inc.
$28
Arbor Pharmaceuticals, Inc.
$21
Bioventus LLC
$19
Biohaven Pharmaceuticals, Inc.
$19
Avanos Medical
$18
Kowa Pharmaceuticals America, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$17
VERTEX PHARMACEUTICALS INCORPORATED
$15
Top 3 companies account for 44.6% of total payments
Associated products mentioned in payments ›
ANJESO · BELBUCA · BELSOMRA · BOTOX · Belbuca · Brainsway Deep TMS · Crysvita · EMGALITY · Evoke · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GELSYN-3 · GRALISE · Horizant · INTELLIS ADAPTIVESTIM · KRYSTEXXA · KYPHON Balloon Kyphoplasty · Kloxxado · LICART · Licart · Lucemyra · MOVANTIK · Movantik · NALOCET · NAPRELAN · NURTEC ODT · Omnia · PROCLAIM · PROLATE · QULIPTA · QUTENZA · Qutenza · RELISTOR · REYVOW · SEGLENTIS · SPRINT PNS System · STANDARD RF DISPOSABLES · Tirosint · UBRELVY · VYEPTI · XCOPRI · XTAMPZA · ZTLido · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for nurse practitioner - primary care in TX.

Equivalent to $635 per 100 Medicare services performed
Looking for a nurse practitioner - primary care in Dallas?
Compare nurse practitioner - primary cares in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - primary cares nearby

Geographic Context

Nurse Practitioner - Primary Cares within 10 mi
154
Per 100K population
5.9
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Simmons is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (low-engagement, top 3%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Simmons experienced with drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms?
Based on Medicare claims data, Dr. Simmons performed 229 drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Simmons receive payments from pharmaceutical companies?
Yes. Dr. Simmons received a total of $6,533 from 42 companies across 346 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Simmons's costs compare to other nurse practitioner - primary cares in Dallas?
Dr. Simmons's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Simmons) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →